查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1873575

角膜移植：全球市場佔有率和排名、總收入和需求預測（2025-2031年）

Corneal Transplant - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
出版日期: | 出版商: QYResearch | 英文 98 Pages | 商品交期: 2-3個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2024 年全球角膜移植市場規模估計為 15.38 億美元，預計到 2031 年將達到 22.87 億美元，在預測期（2025-2031 年）內複合年成長率為 6.2%。

角膜移植（角膜成形術）是一種常見的移植手術，成功率非常高，能夠用透明、健康的角膜替換有疤痕、疼痛、穿孔、變形或渾濁的角膜（虹膜和瞳孔前的透明層）。

用於移植的角膜取自近期去世的捐贈者。排斥反應相對罕見，且通常可治療（參見角膜移植併發症）。因此，組織相容性測試並非常規要求。針對水痘角膜病變、圓錐角膜和某些角膜瘢痕等疾病進行的移植手術成功率最高。

廣義上講，角膜移植是指用異體材料取代渾濁或病變的角膜組織，以恢復患者視力、控制角膜疾病或改善外觀的手術。因此，它包括同種異體移植、異種移植、自體移植、組織工程角膜移植和人工角膜移植。角膜移植通常指的是同種異體移植，即使用來自其他捐贈者的健康角膜組織來取代渾濁或病變的角膜組織，以恢復視力或控制角膜疾病。它是恢復視力最重要的同種異體移植之一，成功率最高。本研究的範圍涵蓋在角膜移植過程中產生的各種費用，包括手術費用、耗材費用、角膜費用、麻醉劑以及治療過程中的廢棄物處理費用。

已開發經濟體和新興經濟體的人口老化導致角膜變性和疾病的發生率不斷上升。

與老齡化相關的角膜內皮功能障礙（Fuchs 內皮營養不良）是內皮移植的常見適應症。

外科技術的進步

與傳統 PK 相比，DALK、DSEK 和 DMEK 等微創技術具有恢復更快、視覺效果更好、排斥率更低等優點。

飛秒雷射技術的應用，能夠實現精確的切口和移植片的對齊，提高了手術的成功率。

擴大眼庫和捐贈者計劃

由於公眾意識的提高和政府主導的舉措，許多國家的角膜組織捐贈數量正在增加。

角膜保存技術的進步（例如低溫保存和器官培養）延長了組織保存期，促進了國際組織交換。

醫療費用支出和擴大保險覆蓋範圍

開發中國家可支配收入的增加、醫療保健服務的改善以及保險覆蓋範圍的擴大，都提高了先進眼科手術的可及性。

非營利組織和國際合作在資源匱乏的地區提供外科手術支援。

人工角膜（人工替代物）的創新

對於不適合傳統供體移植或反覆移植失敗的患者，人工替代物（例如 Boston KPro）帶來了希望。

生物相容性材料和設計的進步改善了重症患者的長期治療效果。

本報告旨在全面概述全球角膜移植市場，重點關注總收入、市場佔有率和主要企業的排名，並按地區/國家、類型和應用進行分析。

本報告以2024年為基準年，按銷售收入提供角膜移植市場規模、估算和預測，並包含2020年至2031年的歷史數據和預測數據。透過定量和定性分析，我們幫助讀者制定業務/成長策略，評估市場競爭格局，分析公司在當前市場中的地位，並就角膜移植做出明智的商業決策。

市場區隔

公司

  • CryoLife, Inc.
  • Exactech, Inc.
  • Kohler GmbH
  • Lifeline Scientific
  • LIFECELL CORPORATION
  • Medtronic

按類型分類的細分市場

  • 穿孔性角膜移植術
  • 內皮移植
  • Descemet膜剝離自內皮化
  • 角膜緣幹細胞移植
  • 其他

應用領域

  • 醫院
  • 眼科診所
  • 其他

按地區

  • 北美洲
    • 美國
    • 加拿大
  • 亞太地區
    • 中國
    • 日本
    • 韓國
    • 東南亞
    • 印度
    • 澳洲
    • 亞太其他地區
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 義大利
    • 荷蘭
    • 北歐國家
    • 其他歐洲
  • 拉丁美洲
    • 墨西哥
    • 巴西
    • 其他拉丁美洲
  • 中東和非洲
    • 土耳其
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 其他中東和非洲地區

The global market for Corneal Transplant was estimated to be worth US$ 1538 million in 2024 and is forecast to a readjusted size of US$ 2287 million by 2031 with a CAGR of 6.2% during the forecast period 2025-2031.

Corneal Transplant (keratoplasty) is a common transplantation procedure with a very high success rate. A scarred, severely painful, perforated, deformed or cloudy cornea (the clear layer in front of the iris and pupil) can be replaced with a clear, healthy cornea.

The donated cornea comes from a recently deceased person. Tissue matching is not routinely required because rejection is relatively rare and can usually be treated (see Complications of corneal transplantation). Transplantation is most likely to be successful when it is performed for diseases such as bullous keratopathy, keratoconus and certain corneal scars.

In a broad sense, corneal transplantation refers to replacing cloudy and diseased corneal tissue with foreign materials to achieve the purpose of restoring the patient's vision or controlling corneal diseases and beauty. Therefore, it includes allogeneic corneal transplantation, xenogeneic corneal transplantation, autologous corneal transplantation, tissue-engineered corneal transplantation and artificial corneal transplantation. Corneal transplantation usually refers to allogeneic corneal transplantation, which is to use normal corneal tissue of a foreign body to replace cloudy or diseased corneal tissue to restore vision or control corneal lesions. It is the one with the highest success rate among allogeneic organ transplants and one of the important eye restoration surgeries. The scope of this report is the various expenses incurred during corneal transplantation, including surgical expenses, consumables, cornea, anesthetic drugs, and various disposal costs during the treatment process.

Aging populations in developed and emerging economies lead to higher rates of corneal degeneration and diseases.

Age-related corneal endothelial failure (Fuchs' dystrophy) is one of the common indications for endothelial keratoplasty.

Advancements in Surgical Techniques

Minimally invasive techniques like DALK, DSEK, and DMEK offer faster recovery, better visual outcomes, and lower rejection rates compared to traditional PK.

The adoption of femtosecond lasers for precise cuts and better graft alignment has improved surgical success rates.

Expansion of Eye Banks and Donor Programs

Improved awareness campaigns and government initiatives have increased corneal tissue donations in many countries.

Technological progress in cornea preservation (e.g., hypothermic storage, organ culture) extends tissue shelf-life and facilitates international tissue exchange.

Increasing Healthcare Expenditure & Insurance Coverage

Rising disposable income, better access to healthcare services, and broader insurance coverage in developing economies boost the affordability of advanced eye surgeries.

Non-profit organizations and international collaborations provide support for surgeries in low-resource settings.

Innovation in Artificial Corneas (Keratoprostheses)

For patients unsuitable for traditional donor grafts or repeat graft failure, keratoprostheses (e.g., Boston KPro) offer hope.

Advances in biocompatible materials and design improve long-term outcomes for severe cases.

This report aims to provide a comprehensive presentation of the global market for Corneal Transplant, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Corneal Transplant by region & country, by Type, and by Application.

The Corneal Transplant market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Corneal Transplant.

Market Segmentation

By Company

  • CryoLife, Inc.
  • Exactech, Inc.
  • Kohler GmbH
  • Lifeline Scientific
  • LIFECELL CORPORATION
  • Medtronic

Segment by Type

  • Penetrating Keratoplasty
  • Endothelial Keratoplasty
  • Descemet Stripping Automated Endothelial Keratoplasty
  • Corneal Limbal Stem Cell Transplant
  • Others

Segment by Application

  • Hospital
  • Eye Clinics
  • Others

By Region

  • North America
    • United States
    • Canada
  • Asia-Pacific
    • China
    • Japan
    • South Korea
    • Southeast Asia
    • India
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Netherlands
    • Nordic Countries
    • Rest of Europe
  • Latin America
    • Mexico
    • Brazil
    • Rest of Latin America
  • Middle East & Africa
    • Turkey
    • Saudi Arabia
    • UAE
    • Rest of MEA

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 2: Detailed analysis of Corneal Transplant company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 5: Revenue of Corneal Transplant in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 6: Revenue of Corneal Transplant in country level. It provides sigmate data by Type, and by Application for each country/region.

Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.

Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 9: Conclusion.

Table of Contents

1 Market Overview

  • 1.1 Corneal Transplant Product Introduction
  • 1.2 Global Corneal Transplant Market Size Forecast (2020-2031)
  • 1.3 Corneal Transplant Market Trends & Drivers
    • 1.3.1 Corneal Transplant Industry Trends
    • 1.3.2 Corneal Transplant Market Drivers & Opportunity
    • 1.3.3 Corneal Transplant Market Challenges
    • 1.3.4 Corneal Transplant Market Restraints
  • 1.4 Assumptions and Limitations
  • 1.5 Study Objectives
  • 1.6 Years Considered

2 Competitive Analysis by Company

  • 2.1 Global Corneal Transplant Players Revenue Ranking (2024)
  • 2.2 Global Corneal Transplant Revenue by Company (2020-2025)
  • 2.3 Key Companies Corneal Transplant Manufacturing Base Distribution and Headquarters
  • 2.4 Key Companies Corneal Transplant Product Offered
  • 2.5 Key Companies Time to Begin Mass Production of Corneal Transplant
  • 2.6 Corneal Transplant Market Competitive Analysis
    • 2.6.1 Corneal Transplant Market Concentration Rate (2020-2025)
    • 2.6.2 Global 5 and 10 Largest Companies by Corneal Transplant Revenue in 2024
    • 2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Corneal Transplant as of 2024)
  • 2.7 Mergers & Acquisitions, Expansion

3 Segmentation by Type

  • 3.1 Introduction by Type
    • 3.1.1 Penetrating Keratoplasty
    • 3.1.2 Endothelial Keratoplasty
    • 3.1.3 Descemet Stripping Automated Endothelial Keratoplasty
    • 3.1.4 Corneal Limbal Stem Cell Transplant
    • 3.1.5 Others
  • 3.2 Global Corneal Transplant Sales Value by Type
    • 3.2.1 Global Corneal Transplant Sales Value by Type (2020 VS 2024 VS 2031)
    • 3.2.2 Global Corneal Transplant Sales Value, by Type (2020-2031)
    • 3.2.3 Global Corneal Transplant Sales Value, by Type (%) (2020-2031)

4 Segmentation by Application

  • 4.1 Introduction by Application
    • 4.1.1 Hospital
    • 4.1.2 Eye Clinics
    • 4.1.3 Others
  • 4.2 Global Corneal Transplant Sales Value by Application
    • 4.2.1 Global Corneal Transplant Sales Value by Application (2020 VS 2024 VS 2031)
    • 4.2.2 Global Corneal Transplant Sales Value, by Application (2020-2031)
    • 4.2.3 Global Corneal Transplant Sales Value, by Application (%) (2020-2031)

5 Segmentation by Region

  • 5.1 Global Corneal Transplant Sales Value by Region
    • 5.1.1 Global Corneal Transplant Sales Value by Region: 2020 VS 2024 VS 2031
    • 5.1.2 Global Corneal Transplant Sales Value by Region (2020-2025)
    • 5.1.3 Global Corneal Transplant Sales Value by Region (2026-2031)
    • 5.1.4 Global Corneal Transplant Sales Value by Region (%), (2020-2031)
  • 5.2 North America
    • 5.2.1 North America Corneal Transplant Sales Value, 2020-2031
    • 5.2.2 North America Corneal Transplant Sales Value by Country (%), 2024 VS 2031
  • 5.3 Europe
    • 5.3.1 Europe Corneal Transplant Sales Value, 2020-2031
    • 5.3.2 Europe Corneal Transplant Sales Value by Country (%), 2024 VS 2031
  • 5.4 Asia Pacific
    • 5.4.1 Asia Pacific Corneal Transplant Sales Value, 2020-2031
    • 5.4.2 Asia Pacific Corneal Transplant Sales Value by Region (%), 2024 VS 2031
  • 5.5 South America
    • 5.5.1 South America Corneal Transplant Sales Value, 2020-2031
    • 5.5.2 South America Corneal Transplant Sales Value by Country (%), 2024 VS 2031
  • 5.6 Middle East & Africa
    • 5.6.1 Middle East & Africa Corneal Transplant Sales Value, 2020-2031
    • 5.6.2 Middle East & Africa Corneal Transplant Sales Value by Country (%), 2024 VS 2031

6 Segmentation by Key Countries/Regions

  • 6.1 Key Countries/Regions Corneal Transplant Sales Value Growth Trends, 2020 VS 2024 VS 2031
  • 6.2 Key Countries/Regions Corneal Transplant Sales Value, 2020-2031
  • 6.3 United States
    • 6.3.1 United States Corneal Transplant Sales Value, 2020-2031
    • 6.3.2 United States Corneal Transplant Sales Value by Type (%), 2024 VS 2031
    • 6.3.3 United States Corneal Transplant Sales Value by Application, 2024 VS 2031
  • 6.4 Europe
    • 6.4.1 Europe Corneal Transplant Sales Value, 2020-2031
    • 6.4.2 Europe Corneal Transplant Sales Value by Type (%), 2024 VS 2031
    • 6.4.3 Europe Corneal Transplant Sales Value by Application, 2024 VS 2031
  • 6.5 China
    • 6.5.1 China Corneal Transplant Sales Value, 2020-2031
    • 6.5.2 China Corneal Transplant Sales Value by Type (%), 2024 VS 2031
    • 6.5.3 China Corneal Transplant Sales Value by Application, 2024 VS 2031
  • 6.6 Japan
    • 6.6.1 Japan Corneal Transplant Sales Value, 2020-2031
    • 6.6.2 Japan Corneal Transplant Sales Value by Type (%), 2024 VS 2031
    • 6.6.3 Japan Corneal Transplant Sales Value by Application, 2024 VS 2031
  • 6.7 South Korea
    • 6.7.1 South Korea Corneal Transplant Sales Value, 2020-2031
    • 6.7.2 South Korea Corneal Transplant Sales Value by Type (%), 2024 VS 2031
    • 6.7.3 South Korea Corneal Transplant Sales Value by Application, 2024 VS 2031
  • 6.8 Southeast Asia
    • 6.8.1 Southeast Asia Corneal Transplant Sales Value, 2020-2031
    • 6.8.2 Southeast Asia Corneal Transplant Sales Value by Type (%), 2024 VS 2031
    • 6.8.3 Southeast Asia Corneal Transplant Sales Value by Application, 2024 VS 2031
  • 6.9 India
    • 6.9.1 India Corneal Transplant Sales Value, 2020-2031
    • 6.9.2 India Corneal Transplant Sales Value by Type (%), 2024 VS 2031
    • 6.9.3 India Corneal Transplant Sales Value by Application, 2024 VS 2031

7 Company Profiles

  • 7.1 CryoLife, Inc.
    • 7.1.1 CryoLife, Inc. Profile
    • 7.1.2 CryoLife, Inc. Main Business
    • 7.1.3 CryoLife, Inc. Corneal Transplant Products, Services and Solutions
    • 7.1.4 CryoLife, Inc. Corneal Transplant Revenue (US$ Million) & (2020-2025)
    • 7.1.5 CryoLife, Inc. Recent Developments
  • 7.2 Exactech, Inc.
    • 7.2.1 Exactech, Inc. Profile
    • 7.2.2 Exactech, Inc. Main Business
    • 7.2.3 Exactech, Inc. Corneal Transplant Products, Services and Solutions
    • 7.2.4 Exactech, Inc. Corneal Transplant Revenue (US$ Million) & (2020-2025)
    • 7.2.5 Exactech, Inc. Recent Developments
  • 7.3 Kohler GmbH
    • 7.3.1 Kohler GmbH Profile
    • 7.3.2 Kohler GmbH Main Business
    • 7.3.3 Kohler GmbH Corneal Transplant Products, Services and Solutions
    • 7.3.4 Kohler GmbH Corneal Transplant Revenue (US$ Million) & (2020-2025)
    • 7.3.5 Kohler GmbH Recent Developments
  • 7.4 Lifeline Scientific
    • 7.4.1 Lifeline Scientific Profile
    • 7.4.2 Lifeline Scientific Main Business
    • 7.4.3 Lifeline Scientific Corneal Transplant Products, Services and Solutions
    • 7.4.4 Lifeline Scientific Corneal Transplant Revenue (US$ Million) & (2020-2025)
    • 7.4.5 Lifeline Scientific Recent Developments
  • 7.5 LIFECELL CORPORATION
    • 7.5.1 LIFECELL CORPORATION Profile
    • 7.5.2 LIFECELL CORPORATION Main Business
    • 7.5.3 LIFECELL CORPORATION Corneal Transplant Products, Services and Solutions
    • 7.5.4 LIFECELL CORPORATION Corneal Transplant Revenue (US$ Million) & (2020-2025)
    • 7.5.5 LIFECELL CORPORATION Recent Developments
  • 7.6 Medtronic
    • 7.6.1 Medtronic Profile
    • 7.6.2 Medtronic Main Business
    • 7.6.3 Medtronic Corneal Transplant Products, Services and Solutions
    • 7.6.4 Medtronic Corneal Transplant Revenue (US$ Million) & (2020-2025)
    • 7.6.5 Medtronic Recent Developments

8 Industry Chain Analysis

  • 8.1 Corneal Transplant Industrial Chain
  • 8.2 Corneal Transplant Upstream Analysis
    • 8.2.1 Key Raw Materials
    • 8.2.2 Raw Materials Key Suppliers
    • 8.2.3 Manufacturing Cost Structure
  • 8.3 Midstream Analysis
  • 8.4 Downstream Analysis (Customers Analysis)
  • 8.5 Sales Model and Sales Channels
    • 8.5.1 Corneal Transplant Sales Model
    • 8.5.2 Sales Channel
    • 8.5.3 Corneal Transplant Distributors

9 Research Findings and Conclusion

10 Appendix

  • 10.1 Research Methodology
    • 10.1.1 Methodology/Research Approach
      • 10.1.1.1 Research Programs/Design
      • 10.1.1.2 Market Size Estimation
      • 10.1.1.3 Market Breakdown and Data Triangulation
    • 10.1.2 Data Source
      • 10.1.2.1 Secondary Sources
      • 10.1.2.2 Primary Sources
  • 10.2 Author Details
  • 10.3 Disclaimer

List of Tables

  • Table 1. Corneal Transplant Market Trends
  • Table 2. Corneal Transplant Market Drivers & Opportunity
  • Table 3. Corneal Transplant Market Challenges
  • Table 4. Corneal Transplant Market Restraints
  • Table 5. Global Corneal Transplant Revenue by Company (2020-2025) & (US$ Million)
  • Table 6. Global Corneal Transplant Revenue Market Share by Company (2020-2025)
  • Table 7. Key Companies Corneal Transplant Manufacturing Base Distribution and Headquarters
  • Table 8. Key Companies Corneal Transplant Product Type
  • Table 9. Key Companies Time to Begin Mass Production of Corneal Transplant
  • Table 10. Global Corneal Transplant Companies Market Concentration Ratio (CR5 and HHI)
  • Table 11. Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Corneal Transplant as of 2024)
  • Table 12. Mergers & Acquisitions, Expansion Plans
  • Table 13. Global Corneal Transplant Sales Value by Type: 2020 VS 2024 VS 2031 (US$ Million)
  • Table 14. Global Corneal Transplant Sales Value by Type (2020-2025) & (US$ Million)
  • Table 15. Global Corneal Transplant Sales Value by Type (2026-2031) & (US$ Million)
  • Table 16. Global Corneal Transplant Sales Market Share in Value by Type (2020-2025)
  • Table 17. Global Corneal Transplant Sales Market Share in Value by Type (2026-2031)
  • Table 18. Global Corneal Transplant Sales Value by Application: 2020 VS 2024 VS 2031 (US$ Million)
  • Table 19. Global Corneal Transplant Sales Value by Application (2020-2025) & (US$ Million)
  • Table 20. Global Corneal Transplant Sales Value by Application (2026-2031) & (US$ Million)
  • Table 21. Global Corneal Transplant Sales Market Share in Value by Application (2020-2025)
  • Table 22. Global Corneal Transplant Sales Market Share in Value by Application (2026-2031)
  • Table 23. Global Corneal Transplant Sales Value by Region, (2020 VS 2024 VS 2031) & (US$ Million)
  • Table 24. Global Corneal Transplant Sales Value by Region (2020-2025) & (US$ Million)
  • Table 25. Global Corneal Transplant Sales Value by Region (2026-2031) & (US$ Million)
  • Table 26. Global Corneal Transplant Sales Value by Region (2020-2025) & (%)
  • Table 27. Global Corneal Transplant Sales Value by Region (2026-2031) & (%)
  • Table 28. Key Countries/Regions Corneal Transplant Sales Value Growth Trends, (US$ Million): 2020 VS 2024 VS 2031
  • Table 29. Key Countries/Regions Corneal Transplant Sales Value, (2020-2025) & (US$ Million)
  • Table 30. Key Countries/Regions Corneal Transplant Sales Value, (2026-2031) & (US$ Million)
  • Table 31. CryoLife, Inc. Basic Information List
  • Table 32. CryoLife, Inc. Description and Business Overview
  • Table 33. CryoLife, Inc. Corneal Transplant Products, Services and Solutions
  • Table 34. Revenue (US$ Million) in Corneal Transplant Business of CryoLife, Inc. (2020-2025)
  • Table 35. CryoLife, Inc. Recent Developments
  • Table 36. Exactech, Inc. Basic Information List
  • Table 37. Exactech, Inc. Description and Business Overview
  • Table 38. Exactech, Inc. Corneal Transplant Products, Services and Solutions
  • Table 39. Revenue (US$ Million) in Corneal Transplant Business of Exactech, Inc. (2020-2025)
  • Table 40. Exactech, Inc. Recent Developments
  • Table 41. Kohler GmbH Basic Information List
  • Table 42. Kohler GmbH Description and Business Overview
  • Table 43. Kohler GmbH Corneal Transplant Products, Services and Solutions
  • Table 44. Revenue (US$ Million) in Corneal Transplant Business of Kohler GmbH (2020-2025)
  • Table 45. Kohler GmbH Recent Developments
  • Table 46. Lifeline Scientific Basic Information List
  • Table 47. Lifeline Scientific Description and Business Overview
  • Table 48. Lifeline Scientific Corneal Transplant Products, Services and Solutions
  • Table 49. Revenue (US$ Million) in Corneal Transplant Business of Lifeline Scientific (2020-2025)
  • Table 50. Lifeline Scientific Recent Developments
  • Table 51. LIFECELL CORPORATION Basic Information List
  • Table 52. LIFECELL CORPORATION Description and Business Overview
  • Table 53. LIFECELL CORPORATION Corneal Transplant Products, Services and Solutions
  • Table 54. Revenue (US$ Million) in Corneal Transplant Business of LIFECELL CORPORATION (2020-2025)
  • Table 55. LIFECELL CORPORATION Recent Developments
  • Table 56. Medtronic Basic Information List
  • Table 57. Medtronic Description and Business Overview
  • Table 58. Medtronic Corneal Transplant Products, Services and Solutions
  • Table 59. Revenue (US$ Million) in Corneal Transplant Business of Medtronic (2020-2025)
  • Table 60. Medtronic Recent Developments
  • Table 61. Key Raw Materials Lists
  • Table 62. Raw Materials Key Suppliers Lists
  • Table 63. Corneal Transplant Downstream Customers
  • Table 64. Corneal Transplant Distributors List
  • Table 65. Research Programs/Design for This Report
  • Table 66. Key Data Information from Secondary Sources
  • Table 67. Key Data Information from Primary Sources

List of Figures

  • Figure 1. Corneal Transplant Product Picture
  • Figure 2. Global Corneal Transplant Sales Value, 2020 VS 2024 VS 2031 (US$ Million)
  • Figure 3. Global Corneal Transplant Sales Value (2020-2031) & (US$ Million)
  • Figure 4. Corneal Transplant Report Years Considered
  • Figure 5. Global Corneal Transplant Players Revenue Ranking (2024) & (US$ Million)
  • Figure 6. The 5 and 10 Largest Companies in the World: Market Share by Corneal Transplant Revenue in 2024
  • Figure 7. Corneal Transplant Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
  • Figure 8. Penetrating Keratoplasty Picture
  • Figure 9. Endothelial Keratoplasty Picture
  • Figure 10. Descemet Stripping Automated Endothelial Keratoplasty Picture
  • Figure 11. Corneal Limbal Stem Cell Transplant Picture
  • Figure 12. Others Picture
  • Figure 13. Global Corneal Transplant Sales Value by Type (2020 VS 2024 VS 2031) & (US$ Million)
  • Figure 14. Global Corneal Transplant Sales Value Market Share by Type, 2024 & 2031
  • Figure 15. Product Picture of Hospital
  • Figure 16. Product Picture of Eye Clinics
  • Figure 17. Product Picture of Others
  • Figure 18. Global Corneal Transplant Sales Value by Application (2020 VS 2024 VS 2031) & (US$ Million)
  • Figure 19. Global Corneal Transplant Sales Value Market Share by Application, 2024 & 2031
  • Figure 20. North America Corneal Transplant Sales Value (2020-2031) & (US$ Million)
  • Figure 21. North America Corneal Transplant Sales Value by Country (%), 2024 VS 2031
  • Figure 22. Europe Corneal Transplant Sales Value, (2020-2031) & (US$ Million)
  • Figure 23. Europe Corneal Transplant Sales Value by Country (%), 2024 VS 2031
  • Figure 24. Asia Pacific Corneal Transplant Sales Value, (2020-2031) & (US$ Million)
  • Figure 25. Asia Pacific Corneal Transplant Sales Value by Region (%), 2024 VS 2031
  • Figure 26. South America Corneal Transplant Sales Value, (2020-2031) & (US$ Million)
  • Figure 27. South America Corneal Transplant Sales Value by Country (%), 2024 VS 2031
  • Figure 28. Middle East & Africa Corneal Transplant Sales Value, (2020-2031) & (US$ Million)
  • Figure 29. Middle East & Africa Corneal Transplant Sales Value by Country (%), 2024 VS 2031
  • Figure 30. Key Countries/Regions Corneal Transplant Sales Value (%), (2020-2031)
  • Figure 31. United States Corneal Transplant Sales Value, (2020-2031) & (US$ Million)
  • Figure 32. United States Corneal Transplant Sales Value by Type (%), 2024 VS 2031
  • Figure 33. United States Corneal Transplant Sales Value by Application (%), 2024 VS 2031
  • Figure 34. Europe Corneal Transplant Sales Value, (2020-2031) & (US$ Million)
  • Figure 35. Europe Corneal Transplant Sales Value by Type (%), 2024 VS 2031
  • Figure 36. Europe Corneal Transplant Sales Value by Application (%), 2024 VS 2031
  • Figure 37. China Corneal Transplant Sales Value, (2020-2031) & (US$ Million)
  • Figure 38. China Corneal Transplant Sales Value by Type (%), 2024 VS 2031
  • Figure 39. China Corneal Transplant Sales Value by Application (%), 2024 VS 2031
  • Figure 40. Japan Corneal Transplant Sales Value, (2020-2031) & (US$ Million)
  • Figure 41. Japan Corneal Transplant Sales Value by Type (%), 2024 VS 2031
  • Figure 42. Japan Corneal Transplant Sales Value by Application (%), 2024 VS 2031
  • Figure 43. South Korea Corneal Transplant Sales Value, (2020-2031) & (US$ Million)
  • Figure 44. South Korea Corneal Transplant Sales Value by Type (%), 2024 VS 2031
  • Figure 45. South Korea Corneal Transplant Sales Value by Application (%), 2024 VS 2031
  • Figure 46. Southeast Asia Corneal Transplant Sales Value, (2020-2031) & (US$ Million)
  • Figure 47. Southeast Asia Corneal Transplant Sales Value by Type (%), 2024 VS 2031
  • Figure 48. Southeast Asia Corneal Transplant Sales Value by Application (%), 2024 VS 2031
  • Figure 49. India Corneal Transplant Sales Value, (2020-2031) & (US$ Million)
  • Figure 50. India Corneal Transplant Sales Value by Type (%), 2024 VS 2031
  • Figure 51. India Corneal Transplant Sales Value by Application (%), 2024 VS 2031
  • Figure 52. Corneal Transplant Industrial Chain
  • Figure 53. Corneal Transplant Manufacturing Cost Structure
  • Figure 54. Channels of Distribution (Direct Sales, and Distribution)
  • Figure 55. Bottom-up and Top-down Approaches for This Report
  • Figure 56. Data Triangulation
  • Figure 57. Key Executives Interviewed